Merck has announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021. Mr. Frazier will continue to serve on Merck’s board of directors as executive chairman, for a transition period to be determined by the board.
“It has been a privilege to serve as Merck’s CEO for the past decade and to work with the most dedicated and talented employees and management team in the industry,” said Mr. Frazier. “As executive chairman, I look forward to collaborating with Rob and our board of directors to help Merck achieve even higher levels of success.”
Mr. Frazier joined Merck in 1992 as vice president, general counsel and secretary of the Astra Merck group. He was appointed as vice president of public affairs in 1994, and then in 1997 he assumed the additional responsibilities of assistant general counsel, corporate staff. Mr. Frazier was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In November 2006, he was promoted to executive vice president and general counsel. Mr. Frazier served as executive vice president and president, Global Human Health, from 2007 to 2010. He was named president of Merck in May 2010. Mr. Frazier became Merck’s chief executive officer and a member of its board in January 2011. He became chairman of the board on December 1, 2011.
Mr. Frazier was elected to the ALI in December 1996 and was elected to the Council in 2003. He is a member of the American Academy of Arts and Sciences, the American Philosophical Society, The Business Council, and the American Bar Association. Additionally, Mr. Frazier is co-chair of the Legal Services Corporation’s Leaders Council.
Learn more about Mr. Frazier’s life and career by listening to his episode of ALI’s Oral History Series on Reasonably Speaking.
Video